ClinConnect ClinConnect Logo
Search / Trial NCT06587906

Postoperative Complications Following Skull Base Tumor Resection

Launched by BEIJING TIANTAN HOSPITAL · Sep 5, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the complications that can occur after surgery to remove tumors located at the base of the skull. These tumors can be tricky to operate on because they are near important parts of the brain and nerves. The goal of the trial is to better understand how to manage patients during and after this type of surgery, as many people experience complications afterward.

To participate in this trial, you must be at least 18 years old and in generally good health (a physical status of I to III, meaning no serious health issues). You should be scheduled for elective surgery to remove a skull base tumor and be able to provide written consent. However, if you have serious heart, liver, or lung conditions, or if you have had certain heart problems recently, you may not be eligible. Participants in this trial can expect to be closely monitored during their surgery and recovery, and their experiences will help researchers improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 and above
  • American Society of Anesthesiologists physical status I to III
  • Undergoing elective resection of skull base tumors
  • Obtaining written informed consent
  • Exclusion Criteria:
  • Heart failure, myocarditis, pericarditis, and cardiomyopathy
  • Myocardial ischemia less than 6 months old
  • Severe arrhythmia
  • Severe bradycardia (heart rate below 50 beats per minute)
  • Unable to complete preoperative cardiac assessment
  • Severe liver dysfunction (Child Pugh C-grade)
  • Severe lung diseases

About Beijing Tiantan Hospital

Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.

Locations

Beijing, , China

Patients applied

0 patients applied

Trial Officials

Yuming Peng

Study Chair

Beijing Tiantan Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported